ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Scancell Holdings Plc

Scancell Holdings Plc (SCLP)

9.15
0.15
(1.67%)
Cerrado 08 Febrero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
9.15
Postura de Compra
8.80
Postura de Venta
9.50
Volume Operado de la Acción
381,433
9.00 Rango del Día 9.15
8.75 Rango de 52 semanas 19.50
Capitalización de Mercado [m]
Precio Anterior
9.00
Precio de Apertura
9.00
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,206,996
Acciones en circulación
1,036,781,403
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-16.05
Beneficio por acción (BPA)
-0.01
turnover
-
Beneficio neto
-5.86M

Acerca de Scancell Holdings Plc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Oxford, Gbr
Fundado
-
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9p. Over the last year, Scancell shares have traded in a share price range of 8.75p to 19.50p.

Scancell currently has 1,036,781,403 shares in issue. The market capitalisation of Scancell is £93.31 million. Scancell has a price to earnings ratio (PE ratio) of -16.05.

SCLP Últimas noticias

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

PLC - Oxford, UK-based pharmaceutical firm - Pretax loss multiplies to GBP13.8 million in the six months to October 3 ...

Scancell Holdings Plc Interim Results

Scancell Holdings Plc 30 January 2025   30 January 2025   Scancell Holdings plc ("Scancell" or the "Company")   Interim Results for the six months ended 31 October 2024   Strong clinical...

Scancell Holdings Plc Notice of Interim Results

Scancell Holdings Plc 23 January 2025     Scancell Holdings plc ("Scancell" or the "Company")   Notice of Interim Results   Scancell Holdings plc (AIM: SCLP), a clinical-stage...

Scancell encouraged by early results in cancer vaccine trial

Scancell Holdings PLC on Thursday said its cancer vaccine had achieved early validation for clinical use. The Oxfor ...

Scancell Holdings Plc Modi-1 Vaccine Achieves Early Clinical Validation

Scancell Holdings Plc 09 January 2025    9 January 2025 Scancell Holdings plc ("Scancell" or the "Company")   Scancell's Modi-1 Moditope® Vaccine Achieves Early Clinical Validation in Head and...

Scancell Holdings Plc Result of Retail Offer and Total Voting Rights

Scancell Holdings Plc 09 December 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND...

IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million

PLC - Oxford, England-based developer of immunotherapies - Raises GBP10.3 million from the placing and direct subscri ...

Scancell Holdings Plc Result of Placing and Subscription

Scancell Holdings Plc 05 December 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND...

Scancell Holdings Plc Retail Offer for up to £1 million

Scancell Holdings Plc 04 December 2024     NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW...

Scancell Holdings Plc Proposed fundraise in excess of £8.5 million

Scancell Holdings Plc 04 December 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.85-8.510108.754804219.16047946DE
4-0.6-6.153846153859.7510.258.7512343359.64609771DE
12-6.475-41.4415.62517.58.75120699611.32398847DE
26-7.6-45.373134328416.7519.58.7598677913.46270677DE
52-2.475-21.290322580611.62519.58.7578385112.88329876DE
156-8.35-47.714285714317.529.57.6579785314.69618326DE
2602.231.6546762596.9529.54.35106727815.44281131DE

SCLP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Scancell?
El precio actual de las acciones de Scancell es 9.15p
¿Cuántas acciones de Scancell están en circulación?
Scancell tiene 1,036,781,403 acciones en circulación
¿Cuál es la capitalización de mercado de Scancell?
La capitalización de mercado de Scancell es GBP 93.31M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Scancell?
Scancell ha negociado en un rango de 8.75p a 19.50p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Scancell?
El ratio precio/beneficio de Scancell es -16.05
¿Cuál es la moneda de reporte de Scancell?
Scancell presenta sus resultados financieros en GBP
¿Cuál es el último beneficio anual de Scancell?
El último beneficio anual de Scancell es GBP -5.86M
¿Cuál es la dirección registrada de Scancell?
La dirección registrada de Scancell es BELLHOUSE BUILDING, SANDERS ROAD, OXFORD SCIENCE PARK, OXFORD, OX4 4GD
¿Cuál es la dirección del sitio web de Scancell?
La dirección del sitio web de Scancell es www.scancell.co.uk
¿En qué sector industrial opera Scancell?
Scancell opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ASTAscent Resources Plc
1.90p
(100.00%)
591.55k
NTQEnteq Technologies Plc
2.85p
(58.33%)
17.97M
THRUThruvision Group Plc
3.25p
(30.00%)
307.66k
IMMImmupharma Plc
4.98p
(27.69%)
14.75M
GEXGeorgina Energy Plc
6.375p
(24.39%)
5.16M
BELLBelluscura Plc
1.875p
(-71.15%)
13.68M
APQApq Global Limited
2.00p
(-69.23%)
60.87k
IOMIomart Group Plc
45.40p
(-23.57%)
1.76M
SYMESupply@me Capital Plc
0.002p
(-20.00%)
736.23M
PRMProteome Sciences Plc
3.50p
(-17.45%)
50.06k
SYMESupply@me Capital Plc
0.002p
(-20.00%)
736.23M
ORCPOracle Power Plc
0.017p
(-14.14%)
523.64M
CPAICapai Plc
0.0475p
(7.95%)
355.25M
NTVONativo Resources Plc
0.0017p
(0.00%)
347.62M
MSMNMosman Oil And Gas Limited
0.04p
(2.56%)
263.67M
Mr. Dragon Mr. Dragon 2 minutos hace
Dark Puss; Solutions for those that want to lose their money at the speed of Dark.
DPLS
AZCowboy AZCowboy 2 minutos hace
~ "so-only-u-say" ... "Link It", LINK MY POSTED WORDS' ... ask plisskin / reeko for help ! ! ... trash 40k pluys has ZERO Credibility with these accusations ~

ron has zero to do with this ... ley's see what u have'

AZ
COOP
WALLnut WALLnut 2 minutos hace
Oh yes, your beloved Y90 Betaglue—the miracle glue that nobody’s using. It’s funny how you keep hyping this ‘competitor,’ yet it’s nowhere near clinical use for tumors like RadioGel is aiming for. Meanwhile, RadioGel keeps progressing, securing a new patent, engaging with the FDA, and moving forward
RDGL
SC8 SC8 4 minutos hace
Sorry but RDGL's single "improved" process patent doesn't stop anyone from making a Y90 injectable gel. There is no evidence whatsoever of any performance advantages to any of MK's "improvements" be it the single "improved" process patent or any "improved" application patents pending. Again, anyon
RDGL
Invest-in-America Invest-in-America 5 minutos hace
STBX: Obviously, the FDA tossed an interim 'monkey wrench' in STBX's convoluted & unintelligible Med Tech stuff, because even the FDA couldn't UNDERSTAND what-the-fluck they were talkin' about --- nor otherwise DOING over there!!!

https://media3.giphy.com/media/v1.Y2lkPTc5MGI3Nj
STBX
GBR GBR 6 minutos hace
agree 100%, have said several times on this message board that good or bad,

Veritone's success largely depends on AWS.


And if we rely on what Veritone said, Veritone and AWS partnering on scalable cloud architecture for AI/ML. If Alexa ready to go, then perhap
VERI
toddski toddski 6 minutos hace
No he didn't say anything about that and I don't know when the filings will be submitted. Good guess would be 10K on March 31st, 10Q sometime in May. These filing would have the XMR links and be submitted to Edgar though. A lot more information will be available.
UMAV
Golden Cross Golden Cross 7 minutos hace
💲 $LITM recently announced groundbreaking developments that promise to reshape its trajectory and position it as a key player in the clean energy minerals sector.
https://allcapresearch.com/f/snow-lake-litm-pioneering-the-future-of-clean-energy-minerals

#uranium #lithiu
LITM
Golden Cross Golden Cross 7 minutos hace
$LITM recently announced groundbreaking developments that promise to reshape its trajectory and position it as a key player in the clean energy minerals sector.
https://allcapresearch.com/f/snow-lake-litm-pioneering-the-future-of-clean-energy-minerals

#uranium #lithium #Mining
LITM
fink fink 8 minutos hace
We got that third party now.

And this Third party needs to make change or the next time the other two sides get in power his family is broke and probably dead.,

It's a Presidential term of survival. He's going to have to expose the entire system from WW2. Rewrite histor
GOLD
$Gambler $Gambler 8 minutos hace
Last couple days fintel says shorts have decreased % wise, let's hope that trend continues! Doubtful?
CGAC
Spectra777 Spectra777 8 minutos hace
The comma would indicate he is saying, "My friend (as in you), Omar will..." at least that's how I would have interpreted it versus referring to Omar as his friend.
SEV
chereb19 chereb19 8 minutos hace
There are no competitors. Fantasy products don't count

Facts are facts
RDGL
Wingsjr Wingsjr 9 minutos hace
My Letter; direct and to the point.
Dr. 47,
If you want a million Trumpians supporting MAGA candidates in 2026, FREE FANNIE AND FREDDIE IN 2025! This will give us $500,000,000-$999,999,999 to do just that.
FNMA
trunkmonk trunkmonk 9 minutos hace
Ackman is doing what i been saying for years, BAC is 46, so if they exercise warrants, they will have a tad more shares than BAC. BAC has 7.5b shares, that would put GSEs about 46. again, im sure this will fall on some deaf ears, but guess what, its a fact, and it makes perfect sense. BAC and GSEs w
FNMA
Golden Cross Golden Cross 9 minutos hace
💲 $LITM Snow Lake is now funded for its 2025 exploration program.. Time to move up here.
Think we get acquisition news soon. PT = $2/$5/$10
LITM
chereb19 chereb19 9 minutos hace
Another whopper of a lie from you
RDGL
Sheepdog Sheepdog 10 minutos hace
Maybe someone can find a OTC scam with no operations who doesn't say that they "explore potential strategic alternatives that may include, but are not limited to a sale, merger, Strategic Business Combination or other transaction" ?

Hilarious.....that language identifies them as a sc
GCAN
ThunderousSeer8 ThunderousSeer8 10 minutos hace
Yeah the "haters" are dropping 500 million shares 😂😂😂 c'mon
RDAR
B402 B402 10 minutos hace
Did the supreme court leave the case to the appeals process?
jimr1717 jimr1717 10 minutos hace
“ The facts are IFUS pps will double easily in 2024 from the current pps under .08”

Lmao

No one was Fooled
IFUS
SC8 SC8 10 minutos hace
Please, we already know of at least one competitor. And who cares about BDD now? That was what? 14 months ago? Time has proven BDD to be just another one of MK's distractions.
RDGL
Golden Cross Golden Cross 10 minutos hace
💲 $LITM Snow Lake is now funded for its 2025 exploration program.. Time to move up here.
Think we get acquisition news soon. PT = $2/$5/$10
LITM
Invest-in-America Invest-in-America 10 minutos hace
PLRX: Evidently, POSTING about THIS wildly-volatile stock is permitted only over on iHub's ORION's Board.
PLRX
thecrusher2011 thecrusher2011 11 minutos hace
I think they appreciated the $2 gas and that their brother didn't die in a needless war that didn't accomplish anything.

Su Consulta Reciente

Delayed Upgrade Clock